Jeito Capital Leads $65M Series A to Advance Innovations in Reproductive Medicine

By Daniella Parra Jeito Capital said it led a $65 million Series A funding round in ReproNovo, a biotech company focused on reproductive medicine and women’s health/. ReproNovo is addressing male and female infertility and uterine health advancing in RPN-001, an...